Asian Digital Biobank

Aiming to be the most comprehensive virtual longitudinal & disease dataset for Han Chinese

Our mission

To fill in the gap of Asian genomic data and provide better solutions for precision medicine for the Asian population.

Our Offer in Taiwan

Healthy Aging Longitudinal Study Taiwan (HALST)

NHRI project
A long-term follow-up cohort aiming at identifying determinants and correlation with aging and aging related chronic diseases.
Since 2009, HALST has recruited 5,000 community-dwellers aged 55+ with a 15-year clinical tracking record.
NHRI and PDC4PM have been sequencing over 2000+ consented HALST sample and integrated the data into ADB.
Upcoming HALST 2.0 aiming to recruit 20,000 samples.

Disease Cohort

Integrate existing research projects in Taiwan and seek for co-R&D opportunities
Work with 16 partner hospitals across Taiwan to categorize over 300,000 collected samples by diseases.
CKD, Diabetes, Cardiovascular Disease, Breast Cancer, and HCC are our research priorities.
Genomic data and clinical data integration

Our Approach

Legal-binding Partnership

Establishing agreements with research institutes, hospitals, and public biobanks in Asia to source biospecimens and extend our access to clinical and genomic data.
Leveraging public-private partnerships with population health studies or existing cohort studies.

Global Collaboration

Serving as contract research organizations (CROs) for sample collection, phenotype data management, and logistics for global pharmaceutical companies interested in Asian population drug discoveries.

Gateway to Asia

Partnering with other biobanks in Asia, we help our clients or partners access the datasets and experts in other major Asian countries seamlessly.

Application

Customized Research Collaborations

Tailored services for pharmaceutical and biotech companies engaged in drug discovery, clinical trials, and genomics-driven research, offering bespoke data analysis pipelines and HPC resources based on ADB.

Fee-for-Service bio samples/data Access

Users will pay for access to high-quality and well-phenotype bio samples or data from the ADB or other linked cohort, with additional fees for data integration and analysis services.

Contact Us

We are looking for partners worldwide to improve public health together!